Abstract
We thank Sanchez and Furberg for their thoughtful comments in response to our recent article in JAMA Oncology on the association between body mass index (BMI) and overall survival with immune checkpoint inhibitor therapy for patients with advanced non–small cell lung cancer.1 We agree that the association of body size with survival outcomes in patients with advanced cancer is complex and evolving.
| Original language | English |
|---|---|
| Pages (from-to) | 941-942 |
| Number of pages | 2 |
| Journal | JAMA Oncology |
| Volume | 6 |
| Issue number | 6 |
| Early online date | 23 Apr 2020 |
| DOIs | |
| Publication status | Published - Jun 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Obesity Paradox in Patients With Non–Small Cell Lung Cancer Treated With Immunotherapy—Reply'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver